ft 23 mar 94 drug group slow r amp invest growth invest pharmaceut research develop deceler steepli last year health care reform effort cut spend medicin world top 38 compani far report result increas r amp expenditur 9 6 per cent last year compar industri growth rate 1980 16 20 per cent invest slow follow industri warn r amp spend unsustain govern intervent control drug price consumpt pharmaceut group struggl poor growth rate world import medicin market increas drug sale top seven european market declin 8 per cent 1992 1 per cent last year drug group respond cut market administr overhead last two year none previous dare cut r amp view life blood industri last year among top 38 pharmaceut group five compani three us one europ one japan forc reduc expenditur includ monsanto marion merrel dow park davi us are serono switzerland shionogi japan dr leon rosenberg presid bristol myer squibb pharmaceut research institut warn headi day r amp 1981 1993 pharmaceut r amp spend rose dollar 5 4bn pound 3 2bn 1981 dollar 26 5bn accord uk base centr medicin research although immedi effect limit time take develop new medicin longer term flow innov medicin threaten mr bryan wright repres japan us pharmaceut manufactur associ said european compani appear less affect us counterpart top 10 european group far report figur increas r amp spend averag 15 4 per cent dollar 6 09bn 1992 dollar 7 1bn last year spent averag 16 9 per cent sale r amp group whose spend rose includ wellcom 30 6 per cent glaxo 24 2 per cent smithklin beecham 20 2 per cent top 10 us group increas r amp spend 8 8 per cent dollar 7 85bn last year dollar 8 5bn averag invest 11 2 per cent turnov r amp top five japanes compani rais spend 6 6 per cent dollar 1 78bn dollar 1 9bn invest 11 4 per cent sale group spend least hit reform among lower level spender top 38 compani r amp spend increas 5 1 per cent us figur follow warn american pharmaceut manufactur associ member expect increas r amp spend 9 4 per cent year first singl digit increas sinc 1977 compar averag annual growth 16 per cent 1980 1992 20 member compani forecast r amp invest growth rate would fall 1994 see pharmaceut r amp survey separ section